Literature DB >> 25320599

Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer.

Soukaina Guaoua1, Ilham Ratbi2, Jaber Lyahyai2, Siham Chafai El Alaoui3, Fatima-Zahra Laarabi3, Abdelaziz Sefiani1.   

Abstract

BACKGROUND: Breast cancer is the most common cancer in women worldwide. About 5 to 10% of cases are due to an inherited predisposition in two major genes, BRCA1 and BRCA2, transmitted as an autosomal dominant form. Male breast cancer is rare and is mainly due to BRCA2 than BRCA1 germline mutations.
OBJECTIVE: Molecular study of BRCA2 gene in man with familial breast cancer.
METHODS: PCR and direct sequencing of BRCA2 gene.
RESULTS: Identification of novel heterozygous germline mutation c.6428C>A ; p.Ser2143Stop of BRCA2 gene.

Entities:  

Keywords:  BRCA2 gene; breast cancer; genetic counseling; male; mutation

Mesh:

Substances:

Year:  2014        PMID: 25320599      PMCID: PMC4196389          DOI: 10.4314/ahs.v14i2.25

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  18 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Hereditary breast and ovarian cancer syndrome.

Authors: 
Journal:  Gynecol Oncol       Date:  2009-04       Impact factor: 5.482

3.  Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

Authors:  L S Friedman; S A Gayther; T Kurosaki; D Gordon; B Noble; G Casey; B A Ponder; H Anton-Culver
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Authors:  Harvey A Risch; John R McLaughlin; David E C Cole; Barry Rosen; Linda Bradley; Isabel Fan; James Tang; Song Li; Shiyu Zhang; Patricia A Shaw; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

5.  BRCA2 germline mutations in male breast cancer cases and breast cancer families.

Authors:  F J Couch; L M Farid; M L DeShano; S V Tavtigian; K Calzone; L Campeau; Y Peng; B Bogden; Q Chen; S Neuhausen; D Shattuck-Eidens; A K Godwin; M Daly; D M Radford; S Sedlacek; J Rommens; J Simard; J Garber; S Merajver; B L Weber
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors.

Authors:  A J Sasco; A B Lowenfels; P Pasker-de Jong
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

7.  Genetic predisposition to breast cancer.

Authors:  H T Lynch; W A Albano; B S Danes; M A Layton; W J Kimberling; J F Lynch; S C Cheng; K A Costello; G M Mulcahy; C A Wagner
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

8.  Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer.

Authors:  Fatima Zahra Laarabi; Imane Cherkaoui Jaouad; Karim Ouldim; Nisrine Aboussair; Abdelouahed Jalil; Brahim El Khalil El Gueddari; Noureddine Benjaafar; Abdelaziz Sefiani
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

Review 9.  Counseling for male BRCA mutation carriers: a review.

Authors:  Hussain B Mohamad; Justus P Apffelstaedt
Journal:  Breast       Date:  2008-07-26       Impact factor: 4.380

10.  The genetic attributable risk of breast and ovarian cancer.

Authors:  E B Claus; J M Schildkraut; W D Thompson; N J Risch
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

View more
  8 in total

1.  First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene.

Authors:  Farah Jouali; Fatima-Zahra Laarabi; Nabila Marchoudi; Ilham Ratbi; Siham Chafai Elalaoui; Houria Rhaissi; Jamal Fekkak; Abdelaziz Sefiani
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

2.  Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.

Authors:  Yihang Shen; Yuan-Hao Lee; Jayabal Panneerselvam; Jun Zhang; Lenora W M Loo; Peiwen Fei
Journal:  Oncotarget       Date:  2015-08-21

3.  Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.

Authors:  Alsmawal A Elimam; Mohamed Elmogtba Mouaweia Mohamed Aabdein; Mohamed El-Fatih Moly Eldeen; Hisham N Altayb; Mohamed Adel Taha; Mohammed N Nimir; Mohamed D Dafaalla; Musaab M Alfaki; Mohamed A Abdelrahim; Abdelmohaymin A Abdalla; Musab I Mohammed; Mona Ellaithi; Muzamil Mahdi Abdel Hamid; Mohamed Ahmed Salih Hassan
Journal:  BMC Med Genet       Date:  2017-08-16       Impact factor: 2.103

4.  High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.

Authors:  Fatima-Zahra Laarabi; Ilham Ratbi; Siham Chafai Elalaoui; Loubna Mezzouar; Yassamine Doubaj; Laila Bouguenouch; Karim Ouldim; Noureddine Benjaafar; Abdelaziz Sefiani
Journal:  BMC Res Notes       Date:  2017-06-02

5.  Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.

Authors:  Jui-Wen Ma; Chao-Ming Hung; Ying-Chao Lin; Chi-Tang Ho; Jung-Yie Kao; Tzong-Der Way
Journal:  Oncotarget       Date:  2016-09-13

6.  Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer.

Authors:  Jean Pascal Demba Diop; Rokhaya Ndiaye Diallo; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Oumar Faye; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  BMC Med Genet       Date:  2019-05-06       Impact factor: 2.103

Review 7.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

Review 8.  Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer.

Authors:  Dylan P McClurg; Gordan Urquhart; Trevor McGoldrick; Subarnarekha Chatterji; Zosia Miedzybrodzka; Valerie Speirs; Beatrix Elsberger
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.